Streptococcal Infections: all 146 studies

Page 1 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation TrialNot yet recruitingNCT07922226Phase 2/3
• A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute PharyngitisRecruitingNCT07891728
• A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)Not yet recruitingNCT07648641
• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young AdultsRecruitingNCT07616934Phase 1
• mulTiplex Immunoassay qualiTy assuRance PanelRecruitingNCT07562061
• Factors Associated With Mortality in Streptococcal Anginosus BacteremiaRecruitingNCT07343167
• Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic InfectionRecruitingNCT07335627
• Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal SepticemiaRecruitingNCT07240077Phase 4
• A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young AdultsRecruitingNCT07085702Phase 1
• Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) RegistryNot yet recruitingNCT06896526
• Group B Streptococcus Infection and PROM IncidinceNot yet recruitingNCT06735703
• Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant Adults.RecruitingNCT05726006
• Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus DiseaseRecruitingNCT04735419
• Serocorrelate of Protection Against GBS (PREPARE WP3)RecruitingNCT04732026
• Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly ParticipantsCompletedNCT05782179Phase 1Results posted
• A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsCompletedNCT05412030Phase 2Results posted
• Immunogenicity and Safety of GBS-NN/NN2 in Pregnant WomenCompletedNCT05154578Phase 2Results posted
• Group B Streptococcus Response After Probiotic ExposureCompletedNCT04721912Phase 3Results posted
• Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIVCompletedNCT04596878Phase 2Results posted
• A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTSCompletedNCT04258995Phase 2Results posted
• Group B Streptococcus Vaccine in Healthy FemalesCompletedNCT03807245Phase 1Results posted
• A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of AgeCompletedNCT03170609Phase 2Results posted
• Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.CompletedNCT02838407Not applicableResults posted
• Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)CompletedNCT02798354Not applicableResults posted
• Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae StrainsCompletedNCT02718157Not applicableResults posted
• A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy InfantsCompletedNCT02447432Phase 3Results posted
• Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent VaccineCompletedNCT02270944Phase 2Results posted
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal InfectionCompletedNCT01746108Phase 3Results posted
• Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™CompletedNCT01641133Phase 3Results posted
• Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy InfantsCompletedNCT01616459Phase 2Results posted
• Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant WomenCompletedNCT01577108Not applicableResults posted
• Evaluation of a Vaccine for Reducing Ear and Lung Infections in ChildrenCompletedNCT01545375Phase 2Results posted
• Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their OffspringsCompletedNCT01446289Phase 2Results posted
• Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their OffspringsCompletedNCT01412801Phase 2Results posted
• Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedNCT01262872Phase 2Results posted
• Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic TreatmentCompletedNCT01235949Phase 4Results posted
• Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy InfantsCompletedNCT01204658Phase 2Results posted
• Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of AgeCompletedNCT01193920Phase 1/2Results posted
• Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850ACompletedNCT01175083Phase 3Results posted
• Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in NigeriaCompletedNCT01153893Phase 3Results posted
• Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in VietnamCompletedNCT01153841Phase 3Results posted
• Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster DoseCompletedNCT01119625Phase 3Results posted
• Oral Health Literacy Tailored CommunicationCompletedNCT01118143Not applicableResults posted
• Booster and Catch-up Vaccination With Vaccine GSK1024850ACompletedNCT01030822Phase 3Results posted
• Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese ChildrenCompletedNCT01027845Phase 3Results posted
• Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First VaccinationCompletedNCT00985751Phase 2Results posted
• Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in MaliCompletedNCT00985465Phase 3Results posted
• Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed ChildrenCompletedNCT00950833Phase 3Results posted
• Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same VaccineCompletedNCT00911144Phase 3Results posted
• Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™CompletedNCT00907777Phase 3Results posted
• Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young AdultsCompletedNCT00896064Phase 2Results posted
• Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive DiseaseCompletedNCT00861380Phase 3Results posted
• Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850ACompletedNCT00839254Phase 3Results posted
• Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.CompletedNCT00829010Phase 3Results posted
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of AgeCompletedNCT00814710Phase 3Results posted
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of AgeCompletedNCT00808444Phase 3Results posted
• Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850ACompletedNCT00792909Phase 3Results posted
• Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™CompletedNCT00680914Phase 3Results posted
• Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™CompletedNCT00678301Phase 3Results posted
• Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/HibCompletedNCT00652951Phase 3Results posted
• Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin InfectionsCompletedNCT00646958Phase 2Results posted
• Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate VaccineCompletedNCT00624819Phase 3Results posted
• Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.CompletedNCT00609492Phase 3Results posted
• Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same VaccinesCompletedNCT00547248Phase 3Results posted
• Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up ScheduleCompletedNCT00513409Phase 2Results posted
• Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850ACompletedNCT00496015Phase 3Results posted
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of AgeCompletedNCT00489554Phase 3Results posted
• COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedNCT00466947Phase 3Results posted
• Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm InfantsCompletedNCT00390910Phase 3Results posted
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.CompletedNCT00370396Phase 3Results posted
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedNCT00345358Phase 3Results posted
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedNCT00344318Phase 3Results posted
• Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose ScheduleCompletedNCT00307034Phase 3Results posted
• Prevention of GBS Colonization Via ImmunityCompletedNCT00128219Phase 2Results posted
• Evaluation of Efficacy of Antibacterial Activity of Licorice, Clove, and Chlorohexidine Mouthwashes on Salivary Streptococcus Mutans in a Group of Egyptian Children.Active, not recruitingNCT07828171Not applicable
• A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)Active, not recruitingNCT07017777Phase 3
• A Strep Throat Controlled Human Infection Trial in Healthy AdultsCompletedNCT06992141Early Phase 1
• Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.Active, not recruitingNCT06611371Phase 1/2
• A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant WomenActive, not recruitingNCT06592586Phase 2/3
• GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of AgeWithdrawnNCT06494475Phase 2/3
• Group A Streptococcus Saliva StudyActive, not recruitingNCT06473506Not applicable
• Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)Active, not recruitingNCT05832502Phase 2
• CandyCollect Strep Throat TestingSuspendedNCT05175196Not applicable
• Streptococcus Pyogenes Carriage Acquisition and Transmission StudyCompletedNCT05117528
• Clinical Performance of the Checkable Medical At-Home Strep A TestCompletedNCT05107362
• A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.CompletedNCT04882514Phase 1/2
• Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)CompletedNCT04841369Phase 3
• Maternal, Neonatal and Infant Outcomes at Kawempe National Referral HospitalActive, not recruitingNCT04653948
• Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive InfectionStatus unknownNCT04594785
• Serosurveillance Study of Maternally Derived Anti-GBS AntibodyActive, not recruitingNCT04549220
• MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDYWithdrawnNCT04227730
• Time Frame for GBS ScreeningWithdrawnNCT04116645
• Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and AboveCompletedNCT04100772Phase 1
• Necrotizing Bacterial Dermohypodermitis-necrotizing Fasciitis Mono- or Multi-microbial Streptococcus Beta-haemolyticStatus unknownNCT03976024Not applicable
• Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal PharyngitisCompletedNCT03777098
• Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute PharyngitisWithdrawnNCT03693495Not applicable
• Colonization with Group B Streptococcus During PregnancyCompletedNCT03671486
• Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant WomenCompletedNCT03669094Not applicable
• Streptoccus Pseudopneumoniae atAssiut UniversityHospitalsStatus unknownNCT03528759
• Antimicrobial Stewardship Program (ASP) in Patients With a Sore ThroatCompletedNCT03408704Not applicable

← Streptococcal Infections overview